ASCO Genitourinary Cancers Symposium
ASCO GU 2022 on the Updated OS Analysis for Docetaxel +/- Capivasertib in mCRPC: A Phase II ProCAID Trial Updates
By
ASCO Genitourinary Cancers Symposium
FEATURING
Simon Crabb
By
ASCO Genitourinary Cancers Symposium
FEATURING
Simon Crabb
Login to view comments.
Click here to Login